South African Press Association - August 18, 2006
Beth Duff-Brown
Others cautioned that the procedure could give men a false sense of security and may not protect women from contracting the disease.
Former United States president Bill Clinton said earlier in the week that while two clinical trials under way in Africa were promising, it would be a "headache" to implement, due to the medical and religious debates surrounding the surgical removal of the foreskin from the penis.
In June, the US National Institutes of Health announced that, following an interim review, two ongoing trials in Uganda and Kenya should continue examining the link between male circumcision and the risk of getting the virus that 40-million people are living with today.
The virulent virus -- for which scientists have yet to develop a vaccine -- has killed an estimated 25-million people since the first cases of HIV were reported 25 years ago.
Between 2003 and 2005, the number of people in low- and middle-income countries on anti-retroviral drugs increased by 450 000 each year. Yet over the same period, the number of people who became infected with HIV averaged more than four million a year.
Data from the trials, scheduled to conclude next year, could validate findings reported in July 2005 from a South African trial, known as the Orange Farm intervention trial, which showed a reduction of 60% in the risk of acquiring HIV among circumcised men.
"The results of the two ongoing trials will help clarify the relationship between male circumcision and risk of HIV in differing contexts, which is key to determining the reproducibility and application of the Orange Farm findings," said Dr Kevin de Cock, head of the World Health Organisation's HIV/Aids programme.
Clinton, whose foundation is heavily involved in Aids programmes, told reporters that while current studies indicate circumcision may be effective, it could lead to a whole new set of personal debate and medical problems.
"I think for men the most promise is in the circumcision studies," Clinton said earlier in the week when asked about the current buzz over promising HIV-prevention tools, such as microbicides for women. "But it's going to be a total headache trying to help them."
Catherine Hankins, chief scientific adviser for the United Nations Joint Programme on HIV/Aids, said researchers are excited about the potential use of circumcision as a tool to fight HIV, but cautioned that it could give men a false sense of security and may not protect women from contracting the infection.
"Even if further trials show a lower risk of HIV infection in circumcised men, male circumcision will not provide complete protection against HIV infection," she said. "Circumcised men can still contract HIV and pass it to their partners. If male circumcision is proven to be effective, it must be considered as just one element of a comprehensive HIV-prevention package."
In Africa, about 70% of men are circumcised at birth or in tribal ceremonies. The soaring HIV infection rates in sub-Saharan Africa are found in communities that do not practice circumcision, such as Swaziland, which has the world's highest HIV infection rate of 33%.
Studies show that HIV infection rates drop dramatically in West Africa and other parts of the continent where circumcision is routinely performed.
Hankins said that tests have shown that the male foreskin is rich in blood cells that are favoured targets of HIV.
060818
SA060817
Copyright © 2006 - South African Press Association. Reproduction of this article (other than one copy for personal reference) must be cleared through the South African Press Association, Cotswold House, Greenacres Office Park, Cnr. Victory & Rustenburg Roads, VICTORY PARK, PO BOX 7766, JOHANNESBURG, 2000; Fax No: +27 11 782-1587/8, Tel No: +27 11 782-1600.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .